Equities

Healthcare Services Group Inc

Healthcare Services Group Inc

Actions
  • Price (EUR)10.60
  • Today's Change0.40 / 3.92%
  • Shares traded--
  • 1 Year change+6.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 15:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Healthcare Services Group Inc had revenues remain flat at 1.69bn, though the company grew net income 12.10% from 34.24m to 38.39m. A reduction in the cost of goods sold as a percentage of sales from 88.70% to 87.22% was a component in the net income growth despite flat revenues.
Gross margin12.66%
Net profit margin1.82%
Operating margin2.18%
Return on assets3.92%
Return on equity6.64%
Return on investment5.27%
More ▼

Cash flow in USDView more

In 2023, Healthcare Services Group Inc increased its cash reserves by 106.74%, or 28.05m. The company earned 43.50m from its operations for a Cash Flow Margin of 2.60%. In addition the company used 3.29m on investing activities and also paid 12.15m in financing cash flows.
Cash flow per share0.5089
Price/Cash flow per share22.71
Book value per share6.42
Tangible book value per share5.25
More ▼

Balance sheet in USDView more

Healthcare Services Group Inc has a Debt to Total Capital ratio of 5.98%.
Current ratio2.74
Quick ratio2.65
Total debt/total equity0.0636
Total debt/total capital0.0598
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.59%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-14.34
EPS (TTM) vs
TTM 1 year ago
-14.30
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.